StockData
HCW Biologics Inc. logo

HCW Biologics Inc. (HCWB) stock

HCWBNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 6/3095% below fair value
$0.76−0.01 (-1.65%)

Close on Nov 18, 2026Market cap $1.40MP/E –Yield –

HCW Biologics enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

HCW Biologics's enterprise value was $6.50M on Nov 11, 2026, against $9.00M a year earlier. Over the last 5 years it ranged from -$16.52M to $70.69M, with a median of $17.81M.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$6.50M-9.9%
2025Dec 31, 2025$7.22M-67.1%
2024Dec 31, 2024$21.94M-33.2%
2023Dec 29, 2023$32.87M-22.3%
2022Dec 30, 2022$42.31M–
2021Dec 31, 2021-$14.53M–

More HCW Biologics figures

See a number that looks wrong?